Medtronic’s Attain Stability Quad MRI SureScan Left Heart Lead Receives FDA’s Approval for Heart Failure

Shots:

• The Attain Stability Quad MRI Surescan left heart lead with quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) & pacemakers (CRT-P) is targeted for precise lead placement and stability and will be available in the US in H1’19
• The Attain Stability Quad lead is a quadripolar lead with a side-helix allowing the physicians to fixate the leads in sizes of veins
• CRT is an implantable device sending leads for the stimulation of heart muscles leading to an improvement in heart pumping efficiency to treat heart failure. Additionally, Medtronic’s portfolio has therapies & diagnostic tools for HF including MR-conditional CRT-Ds and CRT-Ps

Click here to read full press release/ article | Ref: GlobeNewswire | Image: Gizmodo